Skip to Content

Abingdon Health PLC ABDX

Rating as of

Morningstar’s Analysis

Currency in GBX
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in the healthcare sector and other industries. The company's product, AbC-19, an antibody test for Covid-19 indicating whether a person is generating IgG antibodies to the spike protein of the SARS-CoV-2 virus. Also, the company produces lateral flow tests covering areas such as self-test HIV, equine infection, human fertility, blood cancer and other infectious diseases.

York Biotech Campus, Sand Hutton
York, YO41 1LZ, United Kingdom
T +44 1904406082
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings
Fiscal Year End Jun 30, 2021
Stock Type
Employees 48